You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
启明医疗(02500.HK)急涨近11% 拟折让2.6%配新股净筹逾14亿加快产品研发
阿思达克 01-22 14:40
启明医疗-B(02500.HK)折让2.6%配股净筹逾14亿元,该股连升第六天,今天急涨10.6%,报90.9元,股价直逼去年10月所创纪录高位97元,成交倍增至870万股,涉资7.6亿元。

启明是内地领先的经导管心脏瓣膜医疗器械商,股份於去年底以每股33元来港上市。公司宣布,拟以每股80.08元(仅较昨天收市价折让2.6%)配售1,804.25万股新H股或占扩大後已发行H股总数约4.18%,料所得款项净额约14.27亿元,将用作加快公司於研产品开发及研究,其中包括Venus PowerX Valve、Venus Vitae Valve、临床前阶段主动瓣膜修复装置(Leaflex)、经导管二尖瓣置换术(TMVR)、经导管三尖瓣置换术(TTVR)等产品和技术,以及其他新技术开发和投资等运营资金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account